News

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...
There are promising new results in animal models whereby mesenchymal stem cells (MSCs) can be used as vehicles for targeted therapies. The use of MSCs as therapeutic biological vehicles in cell ...
Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...
Acquisition of mesenchymal markers during ... Molecular characterization of CTCs and targeted therapies. Signaling pathways represented in CTCs regulating stem cells, proliferation and survival ...
BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis: New York Wednesday, May 21, 2025, 18:00 Hrs [IST] BrainStorm Cell Therapeutics ...
Targeted injection of mesenchymal precursor cells (MPCs) into the myocardium is safe but does not reduce recurrent nonfatal decompensated heart failure (HF) events in patients with chronic HF with ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
The promise of mesenchymal stem cells (MSCs) to heal heart disease could be around the corner thanks to a new delivery method tested by regenerative medicine company Cynata Therapeutics Ltd.
“This particular study,” she said, “focuses on the newer treatment of mesenchymal stem cell therapy as a treatment for knee osteoarthritis. Mesenchymal stem cells may be bone-marrow ...
In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...